Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.

Thrombosis and haemostasis - 1 Oct 2024

Guillet Benoît, Pawlowski Maxime, Boisseau Pierre, Répessé Yohann, Beurrier Philippe, Bayart Sophie, Delavenne Xavier, Trossaërt Marc, Lenting Peter J

Abstract excerpt

BACKGROUND: Desmopressin (DDAVP) is used in patients with moderate/mild hemophilia A (PWMHs) to increase their factor VIII (FVIII) level and, if possible, normalize it. However, its effectiveness varies between individuals. The GIDEMHA study aims to investigate the influence of F8 gene variants. MATERIAL AND METHODS: The study collected the trajectory of FVIII levels from therapeutic intravenous DDAVP tests in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Deamino Arginine Vasopressin
Share to Factor VIII

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to France

Share to Half-Life

Share to Hemophilia A

Share to Hemostatics

Share to Treatment Outcome

Share to Young Adult

Source

Identifiers

PMID: 38759975
DOI: 10.1055/a-2329-3375

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.PMID 38759975Read ↗

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.Semantic proximity Read ↗

Desmopressin in moderate hemophilia A patients: a treatment worth considering.Semantic proximity Read ↗

Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.Semantic proximity Read ↗

Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia.Semantic proximity Read ↗

Navigation of the Hemophilia Drug Choice-Paralysis: A Quick User Guide to New and Existing TherapiesSemantic proximity Read ↗

Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks.Semantic proximity Read ↗

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.Semantic proximity Read ↗

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs.Semantic proximity Read ↗

Inhibitors to Factor VIII in a Family with Mild Hemophilia: Molecular Characterization and Response to Factor VIII and DesmopressinSemantic proximity Read ↗

Common Genetic Variants in ABO and CLEC4M Modulate the Pharmacokinetics of Recombinant FVIII in Severe Hemophilia A Patients.Semantic proximity Read ↗

The natural history of mild haemophilia: a 30-year single centre experience.Semantic proximity Read ↗

Emerging therapies for hemophilia: controversies and unanswered questionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.